(Q49068807)

English

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

0 references

Geraldo Busatto Filho

1 reference

ORCID Public Data File 2021

author name string

L S Pilowsky

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

G F Busatto

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

M Taylor

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

D C Costa

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

T Sharma

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

T Sigmundsson

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

P J Ell

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

V Nohria

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

R W Kerwin

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

publication date

1 March 1996

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

124

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

1-2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

148-153

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

https://scigraph.springernature.com/pub.10.1007/bf02245615

0 references

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

1 reference

https://api.crossref.org/works/10.1007%2FBF02245615

21 January 2018

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1007%2FBF02245615

21 January 2018

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical profile of clozapine: adverse reactions and agranulocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for drug-induced akathisia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical profile of risperidone, a new antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine receptors in human brain: autoradiographic distribution of D2 sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8935810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02245615

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/8935810

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49068807&oldid=1786187533"